Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q2 2020 Update
09:47am, Wednesday, 26'th Aug 2020
Prem Watsa’s 13F portfolio value increased from $1.44B to $1.59B this quarter. Fairfax Financials’ largest three stakes are Atlas Corp., BlackBerry, and Kennedy-Wilson.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 19)
10X Genomics Inc (NASDAQ: TXG)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Avenue Therapeutics Inc (NASDAQ: ATXI)...
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
12:00am, Wednesday, 19'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 18)
Avenue Therapeutics Inc (NASDAQ: ATXI)
Checkmate Pharmaceuticals Inc (NASDAQ: CMPI)
DarioHealth Corp (NASDAQ:...
Pacific Biosciences (PACB) Catches Eye: Stock Jumps 6.6%
12:43pm, Tuesday, 18'th Aug 2020
Pacific Biosciences (PACB) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 17)
Catalent Inc (NYSE: CTLT)
CureVac N.V. (NASDAQ: CVAC) (follow-on buying after a 250% advance on its debut Friday...
Why Pacific Biosciences of California Shares Are Soaring Today
04:51pm, Wednesday, 12'th Aug 2020
Shares of Pacific Biosciences of California (NASDAQ: PACB) were soaring 25.6% as of 11:54 a.m. EDT on Wednesday. The big gain came after the gene-sequencing systems maker announced a public stock off
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
03:20am, Wednesday, 12'th Aug 2020
MENLO PARK, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its pre
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
08:32pm, Tuesday, 11'th Aug 2020
MENLO PARK, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $75.0 million of shares of its common sto
Did Hedge Funds Make The Right Call On Pacific Biosciences of California, Inc. (PACB) ?
05:02pm, Monday, 10'th Aug 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Pacific Biosciences Announces New Chief Executive Officer
12:30pm, Friday, 07'th Aug 2020
Christian O. Henry Named Chief Executive Officer John F. Milligan, Ph.D. Named Chairman of the Board Ben Gong Named Interim CFOMENLO PARK, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Pacific Bioscienc
Pacific Biosciences Looking Toward Labs Getting Back To Work (NASDAQ:PACB)
07:50pm, Wednesday, 05'th Aug 2020
PacBio is seeing signs of labs and research centers reopening, and consumables utilization is improving, but system placements and consumables pull-through have been significantly stunted by the COVID
Pacific Biosciences (PACB) Posts Lower-Than-Expected Q2 Loss
12:14pm, Tuesday, 04'th Aug 2020
Pacific Biosciences (PACB) saw revenue decline in both its operating segments in Q2.
What's Behind Pacific Biosciences of California's Ugly Q2 Results? | The Motley Fool
10:40am, Tuesday, 04'th Aug 2020
The gene-sequencing systems maker posted big top- and bottom-line declines in the second quarter.
Pacific Biosciences of California (PACB) Q2 2020 Earnings Call Transcript | The Motley Fool
06:01am, Tuesday, 04'th Aug 2020
PACB earnings call for the period ending June 30, 2020.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
